Optimer Pharmaceuticals, Inc. (OPTR) has a tradablOptimer Pharmaceuticals, Inc.
(OPTR) has a tradable event on April 5th, 2011, an FDA Advisory Committee Meeting for
Fidaxomicin their lead drug candidate.
There is an information package at Biotechnology Events
https://www.biotechnologyevents.com/
I am considering a "long strangle" option position, the April 11th $12.50 calls with the April 11th $10.00 puts.
JJS